ERNESTO CRISTIAN: Open Payments
NPI 1891343901 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 50 payments from 13 companies in 2025. Trend: 2023 $668 · 2024 $1,227 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $325 |
| Lundbeck LLC | 11 | $196 |
| Axsome Therapeutics, Inc. | 5 | $107 |
| E.R. Squibb & Sons, L.L.C. | 3 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $34 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $19 |
Products named: CAPLYTA, REXULTI, Auvelity, COBENFY, INGREZZA, AUSTEDO XR, INVEGA SUSTENNA, Jornay PM.
Industry payments across FL — which companies pay providers there.
